Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Mar. 31, 2019 | May 17, 2019 | |
Document and Entity Information [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Mar. 31, 2019 | |
Document Fiscal Year Focus | 2019 | |
Document Fiscal Period Focus | Q1 | |
Entity Registrant Name | PLEDGE PETROLEUM CORP | |
Entity Central Index Key | 0001434110 | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Non-accelerated Filer | |
Trading Symbol | PROP | |
Entity Common Stock, Shares Outstanding | 484,256,464 | |
Entity Emerging Growth Company | false | |
Entity Small Business | true |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) | Mar. 31, 2019 | Dec. 31, 2018 |
Current assets: | ||
Cash | $ 204 | $ 21,140 |
Prepaid expenses | 12,988 | 11,270 |
Prepaid stock compensation – related party | 108,333 | 133,333 |
Total current assets | 121,525 | 165,743 |
Plant and equipment, net | 2,623 | 3,885 |
Deposits | 0 | 1,750 |
Total assets | 124,148 | 171,378 |
Current liabilities: | ||
Accounts payable | 171,149 | 81,097 |
Accrued expenses and other payables | 13,154 | 11,521 |
Accrued interest | 1,919 | |
Derivative liability | 181,967 | 0 |
Convertible note payable, net of discount of $83,529 | 19,471 | 0 |
Due to related parties | 62,704 | 5,890 |
Loan payable – related party | 5,000 | 5,000 |
Total current liabilities | 455,364 | 103,508 |
Total liabilities | 455,364 | 103,508 |
Commitments and contingencies | ||
Stockholders' Equity (Deficit): | ||
Common stock, $0.001 par value; 500,000,000 shares authorized, 484,256,464 shares issued and outstanding | 484,257 | 484,257 |
Accumulated deficit | (815,513) | (416,427) |
Total stockholders' (deficit) equity | (331,216) | 67,870 |
Total Liabilities and Stockholders' Deficit | 124,148 | 171,378 |
Series A Convertible Preferred stock [Member] | ||
Stockholders' Equity (Deficit): | ||
Preferred Stock Value | 0 | 0 |
Total stockholders' (deficit) equity | 0 | 0 |
Series B Convertible Preferred Stock [Member] | ||
Stockholders' Equity (Deficit): | ||
Preferred Stock Value | 40 | 40 |
Total stockholders' (deficit) equity | 40 | 40 |
Series C Convertible Preferred Stock [Member] | ||
Stockholders' Equity (Deficit): | ||
Preferred Stock Value | 0 | 0 |
Total stockholders' (deficit) equity | $ 0 | $ 0 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS [Parenthetical] - USD ($) | 3 Months Ended | |
Mar. 31, 2019 | Dec. 31, 2018 | |
Amortization of Debt Issuance Costs and Discounts | $ 83,529 | |
Common Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 |
Common Stock, Shares Authorized | 500,000,000 | 500,000,000 |
Common Stock, Shares, Issued | 484,256,464 | 484,256,464 |
Common Stock, Shares, Outstanding | 484,256,464 | 484,256,464 |
Series A Convertible Preferred stock [Member] | ||
Preferred Stock, Par or Stated Value Per Share | $ 0.01 | $ 0.01 |
Preferred Stock Shares Designated | 5,000,000 | 5,000,000 |
Preferred Stock, Shares Issued | 0 | 0 |
Preferred Stock, Shares Outstanding | 0 | 0 |
Series B Convertible Preferred Stock [Member] | ||
Preferred Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 |
Preferred Stock, Liquidation Preference, Value | $ 480,000 | $ 480,000 |
Preferred Stock Shares Designated | 500,000 | 500,000 |
Preferred Stock, Shares Issued | 40,000 | 40,000 |
Preferred Stock, Shares Outstanding | 40,000 | 40,000 |
Series C Convertible Preferred Stock [Member] | ||
Preferred Stock, Par or Stated Value Per Share | $ 0.001 | $ 0.001 |
Preferred Stock Shares Designated | 4,500,000 | 4,500,000 |
Preferred Stock, Shares Outstanding | 0 | 0 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS | 3 Months Ended |
Mar. 31, 2019USD ($)$ / sharesshares | |
Expenses: | |
Professional fees | $ 31,000 |
Directors fees | 90,000 |
Compensation – related party | 15,000 |
Stock compensation – related party | 25,000 |
General and administrative | 137,729 |
Total expenses | 298,729 |
Loss from operations | (298,729) |
Other income (expense): | |
Interest expense | (1,919) |
Debt discount amortization | (19,471) |
Change in the fair value of convertible debt | 197,153 |
Loss on issuance of convertible debt | (276,120) |
Total other income (expense) | (100,357) |
Loss before Provision for Income Taxes | (399,086) |
Provision for Income Taxes | 0 |
Net Loss | (399,086) |
Undeclared Series B and Series C Preferred stock dividends | (7,890) |
Net loss available to common stockholders | $ (406,976) |
Net Loss Per Share - Basic and Diluted | $ / shares | $ 0 |
Weighted Average Number of Shares Outstanding - Basic and Diluted | shares | 484,256,464 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT - 3 months ended Mar. 31, 2019 - USD ($) | Total | Series A-1 Preferred stock [Member] | Series B Preferred Stock [Member] | Series C Preferred Stock [Member] | Common Stock [Member] | Accumulated Deficit [Member] |
Balance at Dec. 31, 2018 | $ 67,870 | $ 0 | $ 40 | $ 0 | $ 484,257 | $ (416,427) |
Balance (in shares) at Dec. 31, 2018 | 0 | 40,000 | 0 | 484,256,464 | ||
Net loss | (399,086) | $ 0 | $ 0 | $ 0 | $ 0 | (399,086) |
Balance at Mar. 31, 2019 | $ (331,216) | $ 0 | $ 40 | $ 0 | $ 484,257 | $ (815,513) |
Balance (in shares) at Mar. 31, 2019 | 0 | 40,000 | 0 | 484,256,464 |
CONDENSED CONSOLIDATED STATEM_3
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS | 3 Months Ended |
Mar. 31, 2019USD ($) | |
Cash flow from operating activities: | |
Net Loss | $ (399,086) |
Adjustments to reconcile net loss to net cash used in operating activities: | |
Depreciation | 1,262 |
Stock based compensation – related party | 25,000 |
Debt discount amortization | 19,471 |
Change in the fair value of convertible debt | (197,153) |
Loss on issuance of convertible debt | 276,120 |
Changes in operating assets and liabilities: | |
Prepaid expenses | 1,283 |
Other assets | 1,750 |
Accounts payable and accruals | 93,603 |
Due to related parties | 56,814 |
Net cash used in operating activities | (120,936) |
Cash flows from financing activities: | |
Loan from a related party | 6,800 |
Repayment of related party loan | (6,800) |
Proceeds from convertible debt | 100,000 |
Net cash provided by financing activities | 100,000 |
Net decrease in cash | (20,936) |
Cash at beginning of period | 21,140 |
Cash at end of period | 204 |
Cash paid during the period for: | |
Interest | 0 |
Income taxes | $ 0 |
ORGANIZATION AND DESCRIPTION OF
ORGANIZATION AND DESCRIPTION OF BUSINESS | 3 Months Ended |
Mar. 31, 2019 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] | NOTE 1 – ORGANIZATION AND DESCRIPTION OF BUSINESS On December 19, 2018, Pledge Petroleum Corp. (the “Company”) entered into a Share Exchange agreement with Renewable Technology Solutions, Inc. (“RTS”). Pursuant to the terms of the agreement, in exchange for 100% of the RTS shares, the Company will issue a stock certificate registered in the name of the RTS stockholder for 250,000,000 shares of its common stock. The transaction will be accounted for as a “reverse acquisition” and recapitalization, with RTS being the accounting acquirer. A reverse merger transaction with a public company is considered and accounted for as a capital transaction in substance; it is equivalent to the issuance of Pledge’s common stock for the net monetary assets of RTS, accompanied by a recapitalization. Accordingly, the accounting does not contemplate the recognition of unrecorded assets of the accounting acquiree, such as goodwill. Consolidated financial statements presented herein reflect the consolidated RTS was incorporated in the State of Tennessee on August 22, 2018. The Company was formed in order to conduct business in the sourcing and implementation of renewable energy technology. |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended |
Mar. 31, 2019 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies [Text Block] | NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and footnotes for the year ended December 31, 2018 included on the Company’s Form 10-K. The results of the three months ended March 31, 2019 are not necessarily indicative of the results to be expected for the full year ending December 31, 2019. In the opinion of management, all adjustments necessary to present fairly the financial position as of March 31, 2019 and the results of operations and cash flows presented herein have been included in the financial statements. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results of operations for the full year. Use of estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary RTS Fair Value of Financial Instruments The Company follows paragraph 825-10-50-10 of the Financial Accounting Standards Board Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data. The carrying amount of the Company’s financial assets and liabilities, such as cash, prepaid expenses and accrued expenses approximate their fair value because of the short maturity of those instruments. The Company’s notes payable approximates the fair value of such instruments as the notes bear interest rates that are consistent with current market rates. The following table classifies the Company’s liabilities measured at fair value on a recurring basis into the fair value hierarchy as of: March 31, 2019: Description Level 1 Level 2 Level 3 Total Gains and Derivative $ - $ - $ 181,967 $ 197,153 Net Loss per Share Net loss per common share is computed pursuant to section 260-10-45 of the ASC. Basic net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period. The weighted average number of common shares outstanding and potentially outstanding common shares assumes that the Company incorporated as of the beginning of the first period presented. The computation of diluted net loss per share does not assume the issuance of common shares that have an anti-dilutive effect on net loss per share. For the three months ended March 31, 2019, all stock options, unvested restricted stock awards, warrants, convertible preferred stock were excluded from the computation of diluted net loss per share. Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive. Recently issued accounting pronouncements On June 20, 2018, the FASB issued ASU 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations. |
GOING CONCERN
GOING CONCERN | 3 Months Ended |
Mar. 31, 2019 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Substantial Doubt about Going Concern [Text Block] | NOTE 3 – GOING CONCERN The Company’s consolidated financial statements have been prepared on a going concern basis, which assumes that the Company will be able to realize its assets and discharge its liabilities and commitments in the normal course of business for the foreseeable future. The Company has just begun its operations and does not yet have operations or revenue to cover its operating expenses. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon generating profitable operations in the future and/or to obtain the necessary financing to meet the Company’s obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next twelve months with debt and equity financing. While the Company believes that it will be successful in obtaining the necessary financing and generating revenue to fund its operations, meet regulatory requirements and achieve commercial goals, there are no assurances that such additional funding will be achieved and that it will succeed in its future operations. The financial statements of the Company do not include any adjustments that may result from the outcome of these uncertainties. |
CONVERTIBLE NOTE PAYABLE
CONVERTIBLE NOTE PAYABLE | 3 Months Ended |
Mar. 31, 2019 | |
Convertible Notes Payable [Abstract] | |
Convertible Notes Payable [Text Block] | NOTE 4 – CONVERTIBLE NOTE PAYABLE On January 22, 2019, the Company executed a converted promissory note with Redstart Holdings Corp. (“Redstart”) for $103,000. The note is unsecured, bears interest at 10% per annum and matures on January 22, 2020. The note is convertible, after 180 days, into shares of common stock at the rate of 61% (39% discount) of the average of the lowest three trading prices in the twenty trading days preceding the conversion. The Company bifurcated the conversion feature and accounted for it as a derivative liability. The Company recorded the derivative liability at its fair value of $379,120 based on the Black Scholes Merton pricing model and a corresponding debt discount of $103,000 to be amortized utilizing the interest method of accretion over the term of the note. As of March 31, 2019, the Company fair valued the derivative at $181,967. In addition, $19,471 of the debt discount has been amortized to interest expense. A summary of the activity of the derivative liability for the notes above is as follows: Balance at December 31, 2018 $ - Increase to derivative due to new issuances 379,120 Derivative gain due to mark to market adjustment (197,153 ) Balance at March 31, 2019 $ 181,967 A summary of quantitative information about significant unobservable inputs (Level 3 inputs) used in measuring the Company’s derivative liability that are categorized within Level 3 of the fair value hierarchy for the three months ended March 31, 2019 is as follows: Inputs March 31, 2019 Initial Valuation Stock price $ 0.0400 $ 0.0406 Conversion price $ 0.0203 $ 0.0105 Volatility (annual) 316.98 % 318.13 % Risk-free rate 2.60 % 2.59 % Years to maturity .81 1 The development and determination of the unobservable inputs for Level 3 fair value measurements and fair value calculations are the responsibility of the Company’s management |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 3 Months Ended |
Mar. 31, 2019 | |
Related Party Transactions [Abstract] | |
Related Party Transactions Disclosure [Text Block] | NOTE 5 – RELATED PARTY TRANSACTIONS On May 2, 2018, the Company issued to each of its three directors, 10,000,000 shares of restricted common stock, vesting as to 1/3 of the grant immediately, 1/3 of the grant on the one-year anniversary of the grant date and 1/3 of the grant on the two-year anniversary of the grant date. The value of the stock has been debited to prepaid stock compensation and will be amortized over the vesting period. As of March 31, 2019 and December 31, 2018, there is $108,333 and $133,333 of prepaid stock compensation, respectively. The restricted stock granted and exercisable at March 31, 2019 is as follows: Restricted Stock Granted Restricted Stock Vested Grant date price Number Weighted Number Weighted $ 0.01 30,000,000 $ 0.01 10,000,000 $ 0.01 The Company recorded an expense of $25,000 for the three months ended March 31, 2019, related to the restricted stock granted to the directors. As of March 31, 2019 and December 31, 2018, $62,704 and $5,890, respectively, is owed to the three directors of the Company for director fees and various advances for services provided in the normal course of business. All amounts due are unsecured, non-interest bearing and due on demand. On December 31, 2018, the Company executed a promissory note with John Huemoeller, Chairman, for $5,000. The promissory note is unsecured, bears interest at 5% and is due on or before December 31, 2019. |
PREFERRED STOCK
PREFERRED STOCK | 3 Months Ended |
Mar. 31, 2019 | |
Equity [Abstract] | |
Preferred Stock [Text Block] | NOTE 6 – PREFERRED STOCK Series A-1 Preferred The Company has designated 5,000,000 preferred shares as Series A-1 Convertible Preferred Stock (“Series A-1 Shares”). Each share of Series A-1 is convertible into ten shares of common stock and has voting rights equal to the number of shares of common stock that holders can convert into. The Series A-1 Shares are non-redeemable by the Company and are entitled to a liquidation preference of $0.08 per share. Series B Preferred The Company has designated 500,000 preferred shares as Series B Convertible Preferred Stock (“Series B Shares”), with 40,000 Series B Shares issued and outstanding as of March 31, 2019, which are convertible into 4,000,000 shares of common stock. The rights, privileges and preferences of the Series B Shares are summarized as follows: Conversion Each share of the Series B Shares is convertible at any time prior to the issuance of a redemption notice by the Company into such number of shares of Common Stock by dividing the Stated value ($10) of the Series B Shares by $0.10 and is subject to adjustment for dividends or distributions made in common stock, the issue of securities convertible into common stock, stock splits, reverse stock splits, or reclassifications of common stock. Company Redemption The Company has the right, at any time after the date the Series B Shares have been issued, to redeem all or a portion of any Holder's Series B Shares at a price per Series B Share equal to the issue price per Series B Share multiplied by 120%. Voting Rights Each holder of Series B Shares is entitled to vote on all matters submitted to a vote of the stockholders of the Company and is entitled to votes equal to the number of shares of Common Stock into which Series B Shares could be converted, and the holders of shares of Series B Shares and Common Stock will vote together as a single class on all matters submitted to the stockholders of the Company. Dividends The holders of the Series B Shares are entitled to receive cumulative dividends at the rate of eight percent per annum of the issue price per share, accrued daily and payable annually in arrears on December 31st of each year. Such dividends accrue on any given share from the day of original issuance of such share. Such dividends are cumulative, whether or not declared by the Board of Directors, but are non-compounding. Any dividend payable on a dividend payment date may be paid, at the option of the Company, either (i) in cash or (ii) in shares of common stock at an issue price of $0.10 per common share. In the event that pursuant to applicable law or contract the Company is prohibited or restricted from paying in cash the full dividends to which the holders of the Series B Shares are entitled, the cash amount available pursuant to applicable law or contract will be distributed among the holders of the Series B Shares ratably in proportion to the full amounts to which they would otherwise be entitled and any remaining amount due to holders of the Series B Shares will be payable in cash. Liquidation Preference In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, the holders of the Series B Shares are entitled to receive, prior and in preference to any distribution of any assets of the Company to the holders of any other preferred stock of the Company and subordinate to any distribution to the Series A-1 Shares, and prior and in preference to any distribution of any assets of the Company to the holders of the Common Stock, the amount of 120% of the issue price per share. In addition, the Series B holder has agreed to vote to subordinate the series B Preferred stock liquidation preferences to the Series C Preferred stock preferences. The Company has undeclared dividends on the Series B Preferred stock amounting to $193,118 as of March 31, 2019. If the dividends are paid in stock, the beneficial conversion feature of these undeclared dividends will be recorded upon the declaration of these dividends. The computation of loss per common share takes into account these undeclared dividends. Series C Preferred The Company has designated 4,500,000 preferred shares as Series C Convertible Preferred Stock (“Series C Shares”). Each share of Series C is convertible into 120,000,000 shares of common stock and has voting rights equal to the number of shares of common stock that holders can convert into. The Series C Shares are non-redeemable by the Company and are entitled to a liquidation preference. |
STOCK OPTIONS
STOCK OPTIONS | 3 Months Ended |
Mar. 31, 2019 | |
Stockholders' Equity Note [Abstract] | |
Shareholders' Equity and Share-based Payments [Text Block] | NOTE 7 – STOCK OPTIONS The Company’s Board of Directors approved the Company’s 2008 Stock Option Plan (the “Stock Plan”) for the issuance of up to 5,000,000 shares of common stock to be granted through incentive stock options, nonqualified stock options, stock appreciation rights, dividend equivalent rights, restricted stock, restricted stock units and other stock-based awards to officers, other employees, directors and consultants of the Company and its subsidiaries. After the reverse stock split in August 2012, a total of 100,000 shares were available for grant. Subsequent to the reverse split the Board of Directors approved an increase in the number of awards available for grant to 2,100,000 shares. The exercise price of stock options under the Stock Plan is determined by the Board of Directors, and may be equal to or greater than the fair market value of the Company’s common stock on the date the option is granted. Options become exercisable over various periods from the date of grant, and generally expire ten years after the grant date. At March 31, 2019, there were 57,704 plan options outstanding, under the Stock Option Plan. The vesting provisions for these stock options are determined by the board of directors at the time of grant, there are no unvested options outstanding as of March 31, 2019. In the event of the employees’ termination, the Company will cease to recognize compensation expense. A summary of all of our option activity during the period ended March 31, 2019 is as follows: No. of shares Exercise price Weighted From August 22, 2018 - $ - $ - Granted - non-plan options - - - Forfeited/cancelled - - - Exercised - - - Effects of recapitalization from reverse acquisition 57,704 $ 0.65 13.50 3.02 Outstanding December 31, 2018 57,704 $ 0.65 13.50 $ 3.02 Granted - non-plan options - - - Forfeited/cancelled - - - Exercised - - - Outstanding March 31, 2019 57,704 $ 0.65 13.50 $ 3.02 The options outstanding and exercisable at March 31, 2019 are as follows: Options outstanding Options exercisable Exercise price No. of shares Weighted Weighted No. of shares Weighted $ 13.50 3,480 0.21 3,480 $ 12.50 2,000 1.53 2,000 $ 8.50 500 2.25 500 $ 5.00 14,800 2.54 14,800 $ 0.65 36,924 4.00 36,924 57,704 3.29 3.02 57,704 $ 3.02 |
WARRANTS
WARRANTS | 3 Months Ended |
Mar. 31, 2019 | |
Warrant [Member] | |
Stockholders' Equity Note Disclosure [Text Block] | NOTE 8 – WARRANTS The warrants outstanding and exercisable at March 31, 2019 are as follows: Warrants outstanding Warrants exercisable Exercise price No. of shares Weighted Weighted No. of shares Weighted price $ 0.25 1,751,667 0.24 1,751,667 $ 0.15 525,500 0.24 525,500 $ 0.25 1,508,333 0.34 1,508,333 $ 0.15 577,499 0.35 577,499 $ 0.25 968,166 0.35 968,166 $ 0.25 633,333 0.40 633,333 5,964,498 0.29 $ 0.22 5,964,498 $ 0.22 No warrants were issued, forfeited, cancelled or exercised From August 22, 2018 through March 31, 2019. |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 3 Months Ended |
Mar. 31, 2019 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies Disclosure [Text Block] | NOTE 9 – COMMITMENTS AND CONTINGENCIES During the normal course of business, the Company may be exposed to litigation. When the Company becomes aware of potential litigation, it evaluates the merits of the case in accordance with FASB ASC 450-20-50, Contingencies. The Company evaluates its exposure to the matter, possible legal or settlement strategies and the likelihood of an unfavorable outcome. If the Company determines that an unfavorable outcome is probable and can be reasonably estimated, it establishes the necessary accruals. As of March 31, 2019, the Company is not aware of any contingent liabilities that should be reflected in the unaudited condensed consolidated financial statements. |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 3 Months Ended |
Mar. 31, 2019 | |
Subsequent Events [Abstract] | |
Subsequent Events [Text Block] | NOTE 10 – SUBSEQUENT EVENTS Management has evaluated subsequent events pursuant to the requirements of ASC Topic 855, from the balance sheet date through the date the consolidated financial statements were available to be issued and has determined that there are no material subsequent events that require disclosure in the unaudited condensed consolidated financial statements other than as disclosed below. |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 3 Months Ended |
Mar. 31, 2019 | |
Accounting Policies [Abstract] | |
Basis of Accounting, Policy [Policy Text Block] | Basis of presentation The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and footnotes for the year ended December 31, 2018 included on the Company’s Form 10-K. The results of the three months ended March 31, 2019 are not necessarily indicative of the results to be expected for the full year ending December 31, 2019. In the opinion of management, all adjustments necessary to present fairly the financial position as of March 31, 2019 and the results of operations and cash flows presented herein have been included in the financial statements. All such adjustments are of a normal and recurring nature. Interim results are not necessarily indicative of results of operations for the full year. |
Use of Estimates, Policy [Policy Text Block] | Use of estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. |
Consolidation, Policy [Policy Text Block] | Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary RTS |
Fair Value of Financial Instruments, Policy [Policy Text Block] | Fair Value of Financial Instruments The Company follows paragraph 825-10-50-10 of the Financial Accounting Standards Board Level 1: Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2: Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3: Pricing inputs that are generally unobservable inputs and not corroborated by market data. The carrying amount of the Company’s financial assets and liabilities, such as cash, prepaid expenses and accrued expenses approximate their fair value because of the short maturity of those instruments. The Company’s notes payable approximates the fair value of such instruments as the notes bear interest rates that are consistent with current market rates. The following table classifies the Company’s liabilities measured at fair value on a recurring basis into the fair value hierarchy as of: March 31, 2019: Description Level 1 Level 2 Level 3 Total Gains and Derivative $ - $ - $ 181,967 $ 197,153 |
Earnings Per Share, Policy [Policy Text Block] | Net Loss per Share Net loss per common share is computed pursuant to section 260-10-45 of the ASC. Basic net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock and potentially outstanding shares of common stock during the period. The weighted average number of common shares outstanding and potentially outstanding common shares assumes that the Company incorporated as of the beginning of the first period presented. The computation of diluted net loss per share does not assume the issuance of common shares that have an anti-dilutive effect on net loss per share. For the three months ended March 31, 2019, all stock options, unvested restricted stock awards, warrants, convertible preferred stock were excluded from the computation of diluted net loss per share. Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive. |
New Accounting Pronouncements, Policy [Policy Text Block] | Recently issued accounting pronouncements On June 20, 2018, the FASB issued ASU 2018-07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations. |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Accounting Policies [Abstract] | |
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] | The following table classifies the Company’s liabilities measured at fair value on a recurring basis into the fair value hierarchy as of: March 31, 2019: Description Level 1 Level 2 Level 3 Total Gains and Derivative $ - $ - $ 181,967 $ 197,153 |
CONVERTIBLE NOTE PAYABLE (Table
CONVERTIBLE NOTE PAYABLE (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Convertible Notes Payable [Abstract] | |
Schedule of Derivative Liabilities at Fair Value [Table Text Block] | A summary of the activity of the derivative liability for the notes above is as follows: Balance at December 31, 2018 $ - Increase to derivative due to new issuances 379,120 Derivative gain due to mark to market adjustment (197,153 ) Balance at March 31, 2019 $ 181,967 |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] | A summary of quantitative information about significant unobservable inputs (Level 3 inputs) used in measuring the Company’s derivative liability that are categorized within Level 3 of the fair value hierarchy for the three months ended March 31, 2019 is as follows: Inputs March 31, 2019 Initial Valuation Stock price $ 0.0400 $ 0.0406 Conversion price $ 0.0203 $ 0.0105 Volatility (annual) 316.98 % 318.13 % Risk-free rate 2.60 % 2.59 % Years to maturity .81 1 |
RELATED PARTY TRANSACTIONS (Tab
RELATED PARTY TRANSACTIONS (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Related Party Transactions [Abstract] | |
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block] | The restricted stock granted and exercisable at March 31, 2019 is as follows: Restricted Stock Granted Restricted Stock Vested Grant date price Number Weighted Number Weighted $ 0.01 30,000,000 $ 0.01 10,000,000 $ 0.01 |
STOCK OPTIONS (Tables)
STOCK OPTIONS (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Stockholders' Equity Note [Abstract] | |
Share-based Compensation, Stock Options, Activity [Table Text Block] | A summary of all of our option activity during the period ended March 31, 2019 is as follows: No. of shares Exercise price Weighted From August 22, 2018 - $ - $ - Granted - non-plan options - - - Forfeited/cancelled - - - Exercised - - - Effects of recapitalization from reverse acquisition 57,704 $ 0.65 13.50 3.02 Outstanding December 31, 2018 57,704 $ 0.65 13.50 $ 3.02 Granted - non-plan options - - - Forfeited/cancelled - - - Exercised - - - Outstanding March 31, 2019 57,704 $ 0.65 13.50 $ 3.02 |
Restricted Stock Outstanding And Exercisable [Table Text Block] | The options outstanding and exercisable at March 31, 2019 are as follows: Options outstanding Options exercisable Exercise price No. of shares Weighted Weighted No. of shares Weighted $ 13.50 3,480 0.21 3,480 $ 12.50 2,000 1.53 2,000 $ 8.50 500 2.25 500 $ 5.00 14,800 2.54 14,800 $ 0.65 36,924 4.00 36,924 57,704 3.29 3.02 57,704 $ 3.02 |
WARRANTS (Tables)
WARRANTS (Tables) | 3 Months Ended |
Mar. 31, 2019 | |
Stockholders' Equity Note [Abstract] | |
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] | The warrants outstanding and exercisable at March 31, 2019 are as follows: Warrants outstanding Warrants exercisable Exercise price No. of shares Weighted Weighted No. of shares Weighted price $ 0.25 1,751,667 0.24 1,751,667 $ 0.15 525,500 0.24 525,500 $ 0.25 1,508,333 0.34 1,508,333 $ 0.15 577,499 0.35 577,499 $ 0.25 968,166 0.35 968,166 $ 0.25 633,333 0.40 633,333 5,964,498 0.29 $ 0.22 5,964,498 $ 0.22 |
ORGANIZATION AND DESCRIPTION _2
ORGANIZATION AND DESCRIPTION OF BUSINESS (Details Textual) - Renewable Technology Solutions Inc [Member] | 1 Months Ended |
Dec. 19, 2018shares | |
Organization and Description of Business [Line Items] | |
Business Acquisition, Percentage of Voting Interests Acquired | 100.00% |
Number of Shares to be Issued Pursuant to Reverse Acquisition | 250,000,000 |
SUMMARY OF SIGNIFICANT ACCOUN_4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) | Mar. 31, 2019 | Dec. 31, 2018 |
Accounting Policies and Estimates [Line Items] | ||
Derivative, Fair Value, Net | $ 181,967 | $ 0 |
Derivative [Member] | Fair Value, Measurements, Recurring [Member] | ||
Accounting Policies and Estimates [Line Items] | ||
Derivative, Fair Value, Net | 197,153 | |
Derivative [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | ||
Accounting Policies and Estimates [Line Items] | ||
Derivative, Fair Value, Net | 0 | |
Derivative [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | ||
Accounting Policies and Estimates [Line Items] | ||
Derivative, Fair Value, Net | 0 | |
Derivative [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | ||
Accounting Policies and Estimates [Line Items] | ||
Derivative, Fair Value, Net | $ 181,967 |
CONVERTIBLE NOTE PAYABLE (Detai
CONVERTIBLE NOTE PAYABLE (Details) | 3 Months Ended |
Mar. 31, 2019USD ($) | |
Balance | $ 0 |
Increase to derivative due to new issuances | 379,120 |
Derivative gain due to mark to market adjustment | (197,153) |
Balance | $ 181,967 |
CONVERTIBLE NOTE PAYABLE (Det_2
CONVERTIBLE NOTE PAYABLE (Details 1) - $ / shares | 3 Months Ended | 4 Months Ended |
Mar. 31, 2019 | Dec. 31, 2018 | |
Stock price | $ 0.0400 | $ 0.0406 |
Conversion price | $ 0.0203 | $ 0.0105 |
Volatility (annual) | 316.98% | 318.13% |
Risk-free rate | 2.60% | 2.59% |
Years to maturity | 9 months 21 days | 1 year |
CONVERTIBLE NOTE PAYABLE (Det_3
CONVERTIBLE NOTE PAYABLE (Details Textual) - USD ($) | 1 Months Ended | 3 Months Ended | |
Jan. 22, 2019 | Mar. 31, 2019 | Dec. 31, 2018 | |
Debt Instrument, Interest Rate, Stated Percentage | 5.00% | ||
Derivative Liability | $ 379,120 | ||
Debt Instrument, Unamortized Discount | 103,000 | ||
Derivative, Fair Value, Net | 181,967 | $ 0 | |
Amortization of Debt Discount (Premium) | $ 19,471 | ||
Unsecured Debt [Member] | |||
Debt Instrument, Face Amount | $ 103,000 | ||
Debt Instrument, Interest Rate, Stated Percentage | 10.00% | ||
Debt Instrument, Maturity Date | Jan. 22, 2020 | ||
Debt Conversion, Converted Instrument, Rate | 61.00% | ||
Debt Instrument, Convertible, Terms of Conversion Feature | (39% discount) of the average of the lowest three trading prices in the twenty trading days preceding the conversion. |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details) - Grant Date Price [Member] - Restricted Stock [Member] | 3 Months Ended |
Mar. 31, 2019$ / sharesshares | |
Restricted Stock Granted, Number granted | shares | 30,000,000 |
Restricted Stock Granted, Weighted average exercise price | $ / shares | $ 0.01 |
Restricted Stock Vested, Number vested | shares | 10,000,000 |
Restricted Stock Vested, Weighted average exercise price | $ / shares | $ 0.01 |
RELATED PARTY TRANSACTIONS (D_2
RELATED PARTY TRANSACTIONS (Details Textual) - USD ($) | 1 Months Ended | 3 Months Ended | |
May 02, 2018 | Mar. 31, 2019 | Dec. 31, 2018 | |
Related Party Transaction [Line Items] | |||
Share-based Compensation | $ 25,000 | ||
Due to Related Parties, Current | 62,704 | $ 5,890 | |
Debt Instrument, Interest Rate, Stated Percentage | 5.00% | ||
Employee Prepaid Stock Compensation | 108,333 | $ 133,333 | |
Loan Payable To Related Party | $ 5,000 | ||
Vesting Period One [Member] | |||
Related Party Transaction [Line Items] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | 10,000,000 | ||
Vesting Period Two [Member] | |||
Related Party Transaction [Line Items] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | 10,000,000 | ||
Vesting Period Three [Member] | |||
Related Party Transaction [Line Items] | |||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | 10,000,000 | ||
Restricted Stock [Member] | |||
Related Party Transaction [Line Items] | |||
Share-based Compensation | $ 25,000 |
PREFERRED STOCK (Details Textua
PREFERRED STOCK (Details Textual) - USD ($) | 3 Months Ended | |
Mar. 31, 2019 | Dec. 31, 2018 | |
Series A-1 Preferred Stock [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Preferred Stock, Shares Outstanding | 0 | |
Preferred Stock Shares Designated | 5,000,000 | |
Preferred Stock, Liquidation Preference Per Share | $ 0.08 | |
Series B Preferred Stock [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Conversion of Stock, Shares Issued | 4,000,000 | |
Preferred Stock, Shares Issued | 40,000 | 40,000 |
Preferred Stock, Shares Outstanding | 40,000 | 40,000 |
Convertible Preferred Stock, Terms of Conversion | Each share of the Series B Shares is convertible at any time prior to the issuance of a redemption notice by the Company into such number of shares of Common Stock by dividing the Stated value ($10) of the Series B Shares by $0.10 and is subject to adjustment for dividends or distributions made in common stock, the issue of securities convertible into common stock, stock splits, reverse stock splits, or reclassifications of common stock. | |
Preferred Stock, Dividend Payment Terms | Any dividend payable on a dividend payment date may be paid, at the option of the Company, either (i) in cash or (ii) in shares of common stock at an issue price of $0.10 per common share. | |
Undeclared Dividends | $ 193,118 | |
Preferred Stock Shares Designated | 500,000 | 500,000 |
Series C Preferred Stock [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Conversion of Stock, Shares Issued | 120,000,000 | |
Preferred Stock, Shares Outstanding | 0 | 0 |
Preferred Stock Shares Designated | 4,500,000 | 4,500,000 |
STOCK OPTIONS (Details)
STOCK OPTIONS (Details) - Employee Stock Option [Member] - $ / shares | 3 Months Ended | 4 Months Ended |
Mar. 31, 2019 | Dec. 31, 2018 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Shares option activity, Outstanding Balance (in shares) | 57,704 | 0 |
Shares option activity, Granted (in shares) | 0 | 0 |
Shares option activity, Forfeited/cancelled (in shares) | 0 | 0 |
Shares option activity, Exercised (in shares) | 0 | 0 |
Effects of recapitalization from reverse acquisition (in shares) | 57,704 | |
Shares option activity, Outstanding Balance (in shares) | 57,704 | 57,704 |
Exercise price per share, Outstanding Balance (in dollars per share) | $ 3.02 | $ 0 |
Exercise price per share, Granted (in dollars per share) | 0 | 0 |
Exercise price per share, Forfeited/cancelled (in dollars per share) | 0 | 0 |
Exercise price per share, Exercised (in dollars per share) | 0 | 0 |
Exercise price per share, Outstanding Ending (in dollars per share) | 3.02 | 3.02 |
Weighted Average Exercise Price, Effects of recapitalization from reverse acquisition (in dollars per share) | 3.02 | |
Maximum [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Exercise price per share, Outstanding Balance (in dollars per share) | 13.50 | |
Exercise price per share, Outstanding Ending (in dollars per share) | 13.50 | 13.50 |
Exercise Price per share, Effects of recapitalization from reverse acquisition (in dollars per share) | 13.50 | |
Minimum [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Exercise price per share, Outstanding Balance (in dollars per share) | 0.65 | |
Exercise price per share, Outstanding Ending (in dollars per share) | $ 0.65 | 0.65 |
Exercise Price per share, Effects of recapitalization from reverse acquisition (in dollars per share) | $ 0.65 |
STOCK OPTIONS (Details 1)
STOCK OPTIONS (Details 1) - Employee Stock Option [Member] - $ / shares | 3 Months Ended | ||
Mar. 31, 2019 | Dec. 31, 2018 | Aug. 21, 2018 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options Outstanding, Exercise Price | $ 3.02 | $ 3.02 | $ 0 |
Options Outstanding, Number Outstanding (in shares) | 57,704 | 57,704 | 0 |
Options Outstanding, Weighted Average Remaining Contractual life in years | 3 years 3 months 14 days | ||
Options Exercisable, Number Exercisable (in shares) | 57,704 | ||
Options Exercisable, Weighted Average Exercise Price | $ 3.02 | ||
Exercise Price Range One [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options Outstanding, Exercise Price | $ 13.50 | ||
Options Outstanding, Number Outstanding (in shares) | 3,480 | ||
Options Outstanding, Weighted Average Remaining Contractual life in years | 2 months 15 days | ||
Options Exercisable, Number Exercisable (in shares) | 3,480 | ||
Exercise Price Range Two [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options Outstanding, Exercise Price | $ 12.50 | ||
Options Outstanding, Number Outstanding (in shares) | 2,000 | ||
Options Outstanding, Weighted Average Remaining Contractual life in years | 1 year 6 months 10 days | ||
Options Exercisable, Number Exercisable (in shares) | 2,000 | ||
Exercise Price Range Three [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options Outstanding, Exercise Price | $ 8.50 | ||
Options Outstanding, Number Outstanding (in shares) | 500 | ||
Options Outstanding, Weighted Average Remaining Contractual life in years | 2 years 3 months | ||
Options Exercisable, Number Exercisable (in shares) | 500 | ||
Exercise Price Range Four [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options Outstanding, Exercise Price | $ 5 | ||
Options Outstanding, Number Outstanding (in shares) | 14,800 | ||
Options Outstanding, Weighted Average Remaining Contractual life in years | 2 years 6 months 14 days | ||
Options Exercisable, Number Exercisable (in shares) | 14,800 | ||
Exercise Price Range Five [Member] | |||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Options Outstanding, Exercise Price | $ 0.65 | ||
Options Outstanding, Number Outstanding (in shares) | 36,924 | ||
Options Outstanding, Weighted Average Remaining Contractual life in years | 4 years | ||
Options Exercisable, Number Exercisable (in shares) | 36,924 |
STOCK OPTIONS (Details Textual)
STOCK OPTIONS (Details Textual) - Employee Stock Option [Member] - shares | 3 Months Ended | ||
Mar. 31, 2019 | Dec. 31, 2018 | Aug. 21, 2018 | |
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | 5,000,000 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | 100,000 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized | 2,100,000 | ||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | 57,704 | 57,704 | 0 |
WARRANTS (Details)
WARRANTS (Details) - Warrant [Member] | 3 Months Ended |
Mar. 31, 2019$ / sharesshares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Warrants Outstanding, Exercise Price | $ / shares | $ 0.22 |
Warrants Outstanding, Number Outstanding | 5,964,498 |
Warrants Outstanding, Weighted Average Remaining Contractual life in years | 3 months 14 days |
Warrants Exercisable, Number Exercisable | 5,964,498 |
Warrants Exercisable, Weighted Average Exercise Price | $ / shares | $ 0.22 |
Exercise Price Range One [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Warrants Outstanding, Exercise Price | $ / shares | $ 0.25 |
Warrants Outstanding, Number Outstanding | 1,751,667 |
Warrants Outstanding, Weighted Average Remaining Contractual life in years | 2 months 26 days |
Warrants Exercisable, Number Exercisable | 1,751,667 |
Exercise Price Range Two [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Warrants Outstanding, Exercise Price | $ / shares | $ 0.15 |
Warrants Outstanding, Number Outstanding | 525,500 |
Warrants Outstanding, Weighted Average Remaining Contractual life in years | 2 months 26 days |
Warrants Exercisable, Number Exercisable | 525,500 |
Exercise Price Range Three [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Warrants Outstanding, Exercise Price | $ / shares | $ 0.25 |
Warrants Outstanding, Number Outstanding | 1,508,333 |
Warrants Outstanding, Weighted Average Remaining Contractual life in years | 4 months 2 days |
Warrants Exercisable, Number Exercisable | 1,508,333 |
Exercise Price Range Four [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Warrants Outstanding, Exercise Price | $ / shares | $ 0.15 |
Warrants Outstanding, Number Outstanding | 577,499 |
Warrants Outstanding, Weighted Average Remaining Contractual life in years | 4 months 6 days |
Warrants Exercisable, Number Exercisable | 577,499 |
Exercise Price Range Five [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Warrants Outstanding, Exercise Price | $ / shares | $ 0.25 |
Warrants Outstanding, Number Outstanding | 968,166 |
Warrants Outstanding, Weighted Average Remaining Contractual life in years | 4 months 6 days |
Warrants Exercisable, Number Exercisable | 968,166 |
Exercise Price Range Six [Member] | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Warrants Outstanding, Exercise Price | $ / shares | $ 0.25 |
Warrants Outstanding, Number Outstanding | 633,333 |
Warrants Outstanding, Weighted Average Remaining Contractual life in years | 4 months 24 days |
Warrants Exercisable, Number Exercisable | 633,333 |